Ohio State Navbar

Our Team

Julia White, MD




Professor, Radiation Oncology
Director, Breast Radiation Oncology
Vice Chair of Clinical Research, Radiation Oncology
Leader, Breast Disease Specific
Chair, The Klotz Sisters for Cancer Research





  • 2014: The American Board of Radiology Volunteer Service Award
  • 2014: Association of Residents in Radiation Oncology (ARRO) Educator of the Year Award
  • 2013: Volunteer Service Award, The American Board of Radiology. 
  • 2013-Present: American College of Radiology Fellow
  • 2012-Present: US News Top Docs
  • 2005-Present: Best Doctors in America
  • 2005: Spirit of Caring Award, Contributions to the Medical Profession. Presented by Community Memorial Hospital, Advanced Healthcare, and Medical Associates. 
  • 1995: ASTRO Travel Grant - Annual ESTRO Meeting, Paris, France. 

Committee Memberships

  • 2006-Present: Scientific Leadership Council, Member
  • 2007-Present: Radiation Therapy Oncology Group (RTOG) Breast Cancer Committee, Chair
  • 2008-Present: Susan G. Komen Foundation Scientific Peer Review Committee, Local Therapies, Member
  • 2008-Present: Commission on Cancer, American College of Surgeons, Member
  • 2008-Present: National Cancer Institute (NCI) Breast Cancer Steering Group, Member
  • 2008-Present: Breast Cancer Resource Panel, Health Services Research Committee of the American Society for Radiation Oncology (ASTRO).
  • 2009-Present: North American Breast Cancer Groups (NABCG), Member
  • 2009-Present: BIG-NABCG Metastatic Working Group, Member
  • 2011-Present: Susan G. Komen Scholars Program, Member
  • 2013-Present: American College of Radiology Fellow
  • 2014-Present: Co-chair, NRG Oncology Breast Cancer Committee
  • 2014-Present: General Director, NRG Oncology Foundation
  • 2014-Present: Member, Steering Committee, FORDS Manual Revision, American College of Surgeon, ASTRO Representative
  • 2014-Present: APBI Consensus Statement Update Working Group, ASTRO Health Services Research Committee
  • 2015-Present: American Society for Radiation Oncology Funding Advocacy and Clinical Trials (FACT) Committee, Member

Society Memberships

  • American Association for Cancer Education (AACE)
  • American Association for Women Radiologists (AAWR)
  • American Brachytherapy Society (ABS)
  • American Radium Society (ARS)
  • American College of Radiology (ACR)
  • American Society of Breast Disease (ASBD)
  • American Society of Clinical Oncology (ASCO)
  • American Society of Therapeutic Radiology and Oncology (ASTRO)
  • Radiation Therapy Oncology Group (RTOG)
  • Wisconsin Medical Society
  • Wisconsin Radiologic Society (WRS)
  • Wisconsin Society of Radiation Oncologists (WSRO)

Editorial Boards

  • The Breast Journal
  • Journal of Cancer Education
  • The Journal of Clinical Oncology

Journal Reviewer

  • Breast Diseases: A Year Book Quarterly
  • Journal of Cancer Education
  • Journal of Clinical Oncology
  • International Journal of Radiation Oncology Biology Physics
  • Radiation Research
  • Radiotherapy and Oncology
  • The Breast Journal


  •  Vicini F, Winter K, Wong J, Pass H, Rabinovitch R, Chafe S, Arthur D, Petersen I, White J, McCormick B. Initial Efficacy Results of RTOG 0319: Three-Dimensional Conformal Radiation Therapy (3D-CRT) Confined to the Region of the Lumpectomy Cavity for Stage I/II Breast Carcinoma. Int J Radiat Oncol Biol Phys. 77(4):1120-7, July 2010.

  • Wolmark N, Curran WJ, Vicini F, White J, Costantino JP, Arthur D, Kuske R, Rabinovitch R, Julian TB, Parda DS. Response to "Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation" (Int J Radiat Oncol Biol Phys 2010;76:71-78) and "Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation" Int J Radiat Oncol Biol Phys 2009;75:1290-1296). Int J Radiat Oncol Biol Phys. 77(1):317, 2010.

  • Sparano JA, Pisano ED, WHITE JR, Hunt KK, Mamounas EP, Perez EA, Hortobagyi GN, Gralow JR, Comis RL. Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: imaging and local therapy. Breast Cancer Res Treat. 120:273-284, 2010.

  • Qi XS, WHITE J, Rabinovitch R, Merrell K, Sood A, Bauer A, Wilson JF, Miften M, Li XA. Respiratory organ motion and dosimetric impact on breast and nodal irradiation. Int J Radiat Oncol Biol Phys. 78(2):609-17, 2010.

  • Smith BD, Bentzen SM, Correa CR, Hahn CA, Hardenbergh PH, Ibbott GS, McCormick B, McQueen JR, Pierce LJ, Powell SN, Recht A, Taghian AG, Vicini FA, WHITE JR, Hafty BG. Fractionation for Whole Breast Irradiation: An American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline. Int J Radiat Oncol Biol Phys 81(1):59-68, 2010.

  • Allozi R, Li A, WHITE J, Apte A, Tai A, Michalski J, Bosch W, ElNaqa I. Tools for Consensus Analysis of Experts’Contours for Radiotherapy Structure Definitions. Radiotherapy and Oncology. 97(3):572-8, 2010.

  • Bergom C, Kelly T, Morrow N, Wilson JF, Walker A, Xiang MS, Ahn KW, WHITE J. Prone Whole Breast Irradiation Using Three-Dimensional Conformal Radiotherapy in Women Undergoing Breast Conservation for Early Disease Yields High Rates of Excellent to Good Cosmetic Outcomes in Patients With Large and/or pendulous Breasts. Article in Press Int J Radiat Oncol Biol Phys, 2011.

  • Smith GL, Xu Y, Buchholz T, Smith BD, Giordano SH, Haffty BG, Vicini FA, WHITE JR, Arthur DW, Harris JR, Shih YT. Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care. Journal of Clinical Oncology. 29(2):157-165, 2011.

  •  WHITE J. Who Benefits from Nodal Field Irradiation?. Current Breast Cancer Reports. 3:124-130, 2011.

  • Qi XS, WHITE J, Li XA. Is ??/β for breast cancer really low? Radiother Oncol. 100(2):282-8, August 2011.

  • WHITE JR, Meyer JL. Intensity-Modulated Radiotherapy for Breast Cancer: Advances in Whole and Partial Breast Treatment. Radiat Ther Oncol. 43:292-314, 2011.

  • Bovi JA, WHITE J. Radiation Therapy in the Prevention of Brain Metastases. Curr Oncol Rep. 14(1):55-62, February 2012.

  • Qi XS, Hu A, Wang K, Newman F, Crosby M, Hu B, WHITE J, Li XA. Respiration Induced Heart Motion and Indications of Gated Delivery for Left-Sided Breast Irradiation. Int J Radiat Oncol Biol Phys. 82(5):1605-11, April 2012.

  • Ahunbay EE, Robbins J, Christian R, Godley A, WHITE J, Li XA. Interfractional target variations for partial breast irradiation. Int J Rad Onc Biol Phys. 82(5):1594-604, April 2012.

  • Cuttino LW, WHITE JR, Rabinovitch R, Gewirtz DA, Anscher MS, Wazer DE, Vicini FA, Julian TB, Arhtur DW. Accelerated Partial-Breast Irradiation: Trial by Media or By Science?. Int J Radiat Onc Biol Phys. 83(4):1075-7, July 2012.

  • Bergom C, Kelly T, Morrow N, Wilson JF, Walker A, Xiang MS, Ahn KW, WHITE J. Prone Whole Breast Irradiation Using Three-Dimensional Conformal Radiotherapy in Women Undergoing Breast Conservation for Early Disease Yields High Rates of Excellent to Good Cosmetic Outcomes in Patients With Large and/or pendulous Breasts. Int J Radiat Oncol Biol Phys, 83 (3) 821-28, 2012.

  • Kainz K, WHITE J, Chen GP, Hermand J, England M, Li XA. Simultaneous Irradiation of the Breast and Regional Lymph Nodes in Prone Position Using Helical Tomotherapy. Br J Radiol. 85(1018):e899-905, October 2012.

  • Freedman GM, WHITE JR, Arthur DW, Allen Li X, Vicini FA. Accelerated Fractionation with a Concurrent Boost for Early Stage Breast Cancer. Radiother Oncol. 106(1):15-20, 2013.

  • Chafe S, Moughan J, McCormick B, Wong J, Pass H, Rainovitch R, Arthur DW, Petersen I, WHITE J, Vicini FA. Late Toxicity and Patient Self-Assessment of Breast/Appearance/Satisfaction on RTOG 0319: A Phase 2 Trial of 3-Dimensional Conformal Radiation Therapy-Accelerated Partial Breast Irradiation Following Lumpectomy for Stages I and II Breast Cancer. Int J Radiat Oncol Biol Phys. 86(5):854-9, August 2013.

  • WHITE J. Do We Need to Irradiate All Small Invasive Breast Cancers and DCIS?. Am Soc Clin Oncol Educ Book. 2013:40-4, 2013. 

  •  Bergom C, Prior P, Kainz K, Morrow N, Ahunbay E, Walker A, Li A, WHITE J. A Phase I/II Study Piloting Accelerated Partial Breast Irradiation Using CT-Guided Intensity Modulated Radiation Therapy in the Prone Position. Radiother Oncol. 108(2):215-9, August 2013.

  • Lautenschlaeger T, Perry J, Peereboom D, Li B, Ibrahim A, Huebner A, Meng W, WHITE J, Chakravarti A. In vitro Study of Combined Cilengitide and Radiation Treatment in Breast Cancer Cell Lines. Radiat Oncol. 8:246, October 2013.

  • Rabinovitch R, Winter K, Kuske R, Bolton J, Arthur D, Scroggins T, Vicini F, McCormick B, WHITE J. RTOG 95-17, a Phase II Trial to Evaluate Brachytherapy as the Sole Method of Radiation Therapy for Stage I and II Breast Carcinoma – Year-5 Toxicity and Cosmesis. Brachytherapy. 13(1):17-22, January – February 2014.

  • WHITE J, Mamounas E. Locoregional Radiotherapy in Patients with Breast Cancer Responding to Neoadjuvant Chemotherapy: A Paradigm for Treatment Individualization. J Clin Oncol. 32(6):494-5, February 2014.

  • Wood WC, Alvarado M, Buchholz DJ, Hyams D, Hwang S, Manders J, Park C, Solin LJ, WHITE J, Willey S. The Current Clinical Value of the DCIS Score. Oncology. Suppl 2:C2, 1-8, C3, May 2014.

  • Woodward WA, Sneige N, WinterK, Kuerer HM, Hudis C, Rakovitch E, Smith BL, Peirce LJ, Germano I, Pu AT, Walker EM, Grisell DL, WHITE JR, McCormick B, for the Radiation Therapy Oncology Group (RTOG). Web Based Pathology Assessment in RTOG 98-04. J Clin Pathol. 67(9):777-780, September 2014.

  • Moossdorff M, van Roozendaal LM, Strobbe LJ, Aebi S, Cameron DA, Dixon JM, Giuliano AE, Haffty BG, Hickey BE, Hudis CA, Klimberg VS, Koczwara B, Kuhn T, Lippman ME, Lucci A, Piccart M, Smith BD, Tjan-Heijnen VC, van de Velde CJ, Van Zee KJ, Vermorken JB, Viale G, Voogd AC, Wapnir IL, WHITE JR, Smidt ML. Maastricht Delphi Consensus on Event Definitions for Classification of Recurrence in Breast Cancer Research. J Natl Cancer Inst. 106(12), December 2014.

  • McCormick B, Winter K, Hudis C, Kuerer HM, Rakovitch E, Smith BL, Sneige N, Moughan J, Shah A, Germain I, Hartford AC, Rashtian A, Walker EM, Yuen A, Strom EA, Wilcox JL, Vallow LA, Small W Jr, Pu AT, Kerlin K, WHITE J. RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy with Observation. J Clin Oncol. 33(7):709-15, March 2015.

  • Bell EH, Kirste S, Fleming JL, Stegmaier P, Drendel V, MoX, Ling S, Fabian D, Manring I, Jilg CA, Schultze-Seemann W, McNulty M, Zynger D, Martin D, WHITE J, Werner M, Grosu AL, Chakravarti A. A Novel MiRNA-Based Predictive Model for Biochemical Failure Following Post-Prostatectomy Salvage Radiation Therapy. PLoS One. 10(3):e0118745, March 2015.

  • Bazan JG, WHITE J. Imaging of the Axilla Before Preoperative Chemotherapy: Impleciation for Postmastectomy Radiation. Cancer. 121(8):1187-94, April 2015.

  • Chen GP, Liu F, WHITE J, Vicini FA, Freedman GM, Arthur DW, Li XA. A Planning Comparison of 7 Irradiation Options Allowed in RTOG 1005 for Early-Stage Breast Cancer. Med Dosim. 40(1):21-5, Spring 2015.

  • Whelan T, Olivotto I, Parulekar W, Ackerman I, Chua B, Nabid A, Vallis K, WHITE JR, Rousseau P, Fortin A, Pierce L, Manchul L, Chafe S, Nolan MC, Craighead P, Bowen J, McCready DR, Pritchard KI, Gelmon K, Murray Y, Chapman JAW, Chen BE, Levine MN. Regional Nodal Irradiation in Early Stage Breast Cancer. N Engl J Med. Accepted March 2015.

  • Provenzano E, Bossuty V, Symmans WF, Boughey JC, Coles C, Curigliano G, Dixon JM, Esserman L, Fastner G, Kuegn T, Peintinger F, von Minckwitz G, WHITE J, Yang W, Badve S, Denkert C, MacGrogan G, PenaultLlorca F, Viale G, Cameron D. Standardization of pathologic evaluation and reporting of post-neoadjuvant specimens in clinical trials of breast cancer: Recommendations from an international working group. Modern Pathology. Accepted March 2015

  • Bossuty V, Provenzano E, Symmans WF, Boughey JC, Coles C, Curigliano G, Dixon JM, Esserman L, Fastner G, Kuegn T, Peintinger F, von Minckwitz G, WHITE J, Yang W, Badve S, Denkert C, MacGrogan G, PenaultLlorca F, Viale G, Cameron D. Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration. Ann Oncol. 26(7):1280-91, July 2015